Vision moves to calm punters after biotech buy
05 July, 2002 by Tanya HollisVision Systems has moved to calm jittery investors following last week's $94 million purchase of UK biochemical manufacturer Novocastra Laboratories.
IBM's life science focus
04 July, 2002 by Iain ScottOn a recent visit to Sydney, IBM Life Sciences chief Caroline Kovac outlined her views on bio-IT, the life sciences and Australia's potential.
United we crunch
03 July, 2002 by Lafe LowExamining more than 3 billion molecules to determine which ones might treat a particular disease sounds like a lifetime's work, but the Anthrax Research Project (ARP) wrapped up just such a massive screening in 24 days. Of the nearly 3.6 billion molecules analysed, the project identified more than 376,000 as candidates for treating the anthrax bacterium, which would render it ineffective as a weapon.
3-D display puts images in the round
03 July, 2002 by Staff WritersLike something out of the movie Star Wars, start-up Actuality Systems this week uncloaked a 3-D computer display capable of turning flat computer-generated images into what look like solid objects.
AusBiotech seminar teaches biotechs how to play with the 'big boys'
03 July, 2002 by Melissa TrudingerA solid commercialisation plan during product development was one of the key messages from speakers at a recent AusBiotech seminar.
Applied Bio on track with forensics software
03 July, 2002 by Pete YoungLife science device and software company Applied Biosystems has passed a key milestone en route to what may be its largest single sale of bioinformatics products in Australia.
Biotech business incubator to be established in NSW
01 July, 2002 by Iain ScottTechnology business accelerator ATP Innovations has won the tender to establish and operate a $2.5 million biotechnology business incubator at Australian Technology Park, in inner-city Sydney.
Pity the bio-IT pure-players
27 June, 2002 by Tanya HollisFledgling businesses trying to carve themselves a spot in the Australian pure-play bioinformatics sector can be left feeling like television salesmen in the 1950s: everybody knows about the technology, but they're not quite sure if they want to spend their money on it yet.
Biotech software: from DIY to off the shelf
26 June, 2002 by Pete YoungThe task of creating specialised software tools to decipher the complexities of genes and proteins until recently has been a do-it-yourself project for the bio-research community.
Play to your strengths, says IBM's Kovac
26 June, 2002 by Iain ScottCaroline Kovac, the US-based business leader of IBM's Life Sciences division, says Australian biotechnology should remember it is playing in a global market and consider its strengths, including a good education system and strong scientific base.
Capillary Electrophoresis: choosing your machine
24 June, 2002 by Melissa TrudingerSample capacity is at the heart of the decision on what capillary electrophoresis system best fits a lab's needs.
Study: genomics equipment market worth $US2bn by 2007
24 June, 2002 by Iain ScottThe worldwide market for genomics equipment and services used to accelerate drug discovery and development is forecasted to increase from $US987 million this year to more than $US2 billion in 2007, according to a new study by US company Front Line Strategic Consulting.
WA proteomics firm finds Asia welcoming
20 June, 2002 by Pete YoungSingapore is rolling out a warm welcome to Australian expertise in protein biochemistry, according to West Australian company Proteomics International.
Iatia releases software package for imaging
19 June, 2002 by Tanya HollisA software package enabling users of electron microscopes to glean specialised information from their specimens is the second product to be released by newly listed vision sciences company Iatia.
Bioinformatics C of E interim board named
17 June, 2002 by Tanya HollisPlans for Tasmania's Bioinformatics Centre of Excellence are stepping up with the naming of its interim board.
